Haberman D., Estévez-Loureiro R., Benito-Gonzalez T., Denti P., Arzamendi D., Adamo M., Freixa X., Nombela-Franco L., Villablanca P., Krivoshei L., Fam N., Spargias K., Czarnecki A., Pascual I., Praz F., Sudarsky D., Kerner A., Ninios V., Gennari M., Beeri R., Perl L., Wasserstrum Y., Danenberg H., Poles L., George J., Caneiro-Queija B., Scianna S., Moaraf I., Schiavi D., Scardino C., Corpataux N., Echarte-Morales J., Chrissoheris M., Fernández-Peregrina E., Pasquale M.D., Regueiro A., Vergara-Uzcategui C., Iñiguez-Romo A., Fernández-Vázquez F., Dvir D., Maisano F., Taramasso M., Shuvy M.. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. EUROPEAN HEART JOURNAL. 2022; 43(7)DOI:10.1093/eurheartj/ehab496. PMID:34463727. IF:39.300(Q1/1D).

González-Juanatey C., Anguita-Sánchez M., Barrios V., Núñez-Gil I., Gómez-Doblas J.J., García-Moll X., Lafuente-Gormaz C., Rollán-Gómez M.J., Peral-Disdie V., Martínez-Dolz L., Rodríguez-Santamarta M., Viñolas-Prat X., Soriano-Colomé T., Muñoz-Aguilera R., Plaza I., Curcio-Ruigómez A., Orts-Soler E., Segovia J., Maté C., Cequier Á.. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing. PLoS One. 2022; 17DOI:10.1371/journal.pone.0263277. PMID:35143527. IF:3.700(Q2/4D).

Cruz-González I., Torres Saura F., Trejo-Velasco B., Antonio Fernández Díaz J., Fajardo Molina R., del Valle-Fernández R., Moreno Terribas G., Martí Sánchez D., López-Mínguez J.-R., Gomez-Blazquez I., Sanmartin Pena J.-C., Botas J., Martin Lorenzo P., Palazuelos J., Albarrán Rincon R., Mohandes M., Rodriguez Entem F.-J., Martí G., Valero E., Gutiérrez H., Amat-Santos I.J., Nombela-Franco L., Salinas P., Teruel L., Gomez-Hospital J.-A., Arzamendi D., Torres Sanabria M., Calle Pérez G., Cañadas Pruaño D., Pérez de Prado A., Benito González T., Arroyo-Úcar E., Estévez-Loureiro R., Caneiro-Queija B., Ibañez Criado J.L., Ruiz-Nodar J.M.. Impact of operators experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry. Ijc Heart & Vasculature. 2022; 38DOI:10.1016/j.ijcha.2021.100941. PMID:35024431. IF:(Q/D).

Albors C., Mill J., Kjeldsberg H.A., Viladés Medel D., Olivares A.L., Valen-Sendstad K., Camara O.. Sensitivity Analysis of Left Atrial Wall Modeling Approaches and Inlet/Outlet Boundary Conditions in Fluid Simulations to Predict Thrombus Formation. Lecture Notes In Computer Science. 2022; 13593 LNCSDOI:10.1007/978-3-031-23443-9_17. PMID:. IF:(Q/D).

Diez-Lopez, C, Salazar-Mendiguchia, J, Garcia-Romero, E, Fuentes, L, Lupon, J, Bayes-Genis, A, Manito, N, De Antonio, M, Moliner, P, Zamora, E, Catala-Ruiz, P, Cainzos-Achirica, M, Comin-Colet, J, Gonzalez-Costello, J. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2022; 9(1)DOI:10.3390/jcdd9010020. PMID:35050230. IF:2.400(Q3/7D).

Glikson M., Nielsen J.C., Kronborg M.B., Michowitz Y., Auricchio A., Barbash I.M., Barrabes J.A., Boriani G., Braunschweig F., Brignole M., Burri H., Coats A.J.S., Deharo J.-C., Delgado V., Diller G.-P., Israel C.W., Keren A., Knops R.E., Kotecha D., Leclercq C., Merkely B., Starck C., Thylen I., Tolosana J.M., Leyva F., Linde C., Abdelhamid M., Aboyans V., Arbelo E., Asteggiano R., Barón-Esquivias G., Bauersachs J., Biffi M., Birgersdotter-Green U., Bongiorni M.G., Borger M.A., Celutkiene J., Cikes M., Daubert J.-C., Drossart I., Ellenbogen K., Elliott P.M., Fabritz L., Falk V., Fauchier L., Fernández-Aviles F., Foldager D., Gadler F., De Vinuesa P.G.G., Gorenek B., Guerra J.M., Hermann Haugaa K., Hendriks J., Kahan T., Katus H.A., Konradi A., Koskinas K.C., Law H., Lewis B.S., Linker N.J., Løchen M.-L., Lumens J., Mascherbauer J., Mullens W., Nagy K.V., Prescott E., Raatikainen P., Rakisheva A., Reichlin T., Ricci R.P., Shlyakhto E., Sitges M., Sousa-Uva M., Sutton R., Suwalski P., Svendsen J.H., Touyz R.M., Van Gelder I.C., Vernooy K., Waltenberger J., Whinnett Z., Witte K.K.. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). EUROPACE. 2022; 24(1)DOI:10.1093/europace/euab232. PMID:34455427. IF:6.100(Q1/3D).

González-Vílchez F., Gómez-Bueno M., Almenar-Bonet L., Crespo-Leiro M.G., Arizón del Prado J.M., Blázquez-Bermejo Z., Delgado-Jiménez J.F., de Antonio-Ferrer M., Sobrino-Márquez J.M., García-Romero E.. Spanish Heart Transplant Registry. 33rd official report of the Heart Failure Association of the Spanish Society of Cardiology. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2022.06.001. PMID:35850486. IF:(Q/D).

Piccini J.P., Caso V., Connolly S.J., Fox K.A.A., Oldgren J., Jones W.S., Gorog D.A., Viethen T., Neumann C., Mundl H., Patel M.R., Auer J., Hubauer M., Pandzic S., Preishuber E., Primus-Grabscheit C., Reitgruber D., Schmalzer F., Adlbrecht C., Schober A., Hajos J., Keil C., Schratter A., Frick M., Benda M.A., Mächler M., Mutschlechner B., Saely C., Sprenger L., Lichtenauer M., Eber M., Hoppe U., Kolbitsch T., Jirak P.M., Mirna M., Schönbauer R., Bergler-Klein J., Hengstenberg C., Stojkovic S., Scherr D., Manninger-Wünscher M., Rohrer U., Stühlinger M., Schgoer W., Schwarzl J., Pürerfellner H., Derndorfer M., Ebner C., Eder V., Kollias G., Sturmberger T., Sieghartsleitner S., Vijgen J., Koopman P., Dujardin K., Anné W., De Ceuninck M., Tavernier R., Duytschaever M., Knecht S., Missault L., Vandekerckhove Y., Rossenbacker T., Ector B., Charlier F., Debruyne P., Dewilde W., Janssens L., Roosen J., Vankelecom B., Heidbuchel H., Delesie M., Vervoort G., Rombouts H., Vanassche T., Engelen M., Verhamme P., Willems R., Constance C., Pranno N., Cox J., Bata I., Macle L., Aguilar M., Tourigny J.C., Dubuc M., Dyrda K., Guerra P., Khairy P., Mondésert B., Rivard L., Roy D., Tadros R., Talajic M., Thibault B., Nault I., Blier L., Champagne J., Molin F., O'Hara G., Philippon F., Plourde B., Sarrazin J.-F., Steinberg C., Coufal Z., Balazsik D., Mikulica M., Zapeca J., Cermak O., Drasnar T., Falc M., Hornof J., Racz B., Weissova D., Linkova H., Paskova E., Petr R., Sirakova A., Kettner J., Benak A., Holek M., Podpera I., Podperova M., Vancura V., Jandik T., Smid J., Dedek V., Banik J., Durdil V., Hnat T., Lellouche N., Rouffiac S., Taldir G., Bridonneau V., Couffon P., Daudin M., Hamon C., Lacaze J., Quentin A., Thebault C., Boiffard E., Billon O., Miette F., Pouliquen H., Turlotte G., Gorka H., Albert F., Bayle S., Bensaid R., Dasoveanu M., Demichili T., Dutoiu T., Khalil C., Loghin C., Range G., Roussel L., Socié P., Thuaire C., Extramiana F., Algalarrondo V., Boughanmi H., El Mansour N., Mohammad U., Sellier R., Elbaz M., Laperche C., Maury P., Kiss R., Borsanyi T., Gingl Z., Polgar B., Benczur B., Bodor A., Hepp T., Malati E., Nagy L., Erdei N., Kapus J., Kapus K., Toth B., Matoltsy A., Kiss T., Merkely B., Herczeg S., Kiss O., Sallo Z., Toth K., Habon T., Rabai M., Totsimon K., Zilahi Z., Bencze G., Santa J., Aradi D., Kelemen B., Bolognese L., Nesti M., Notarstefano P.G., D'Orazio S., Cosmi F., Becattini C., Agnelli G., Broccatelli B., Mosconi M.G., Paciaroni M., Urbini C., Parato V.M., Notaristefani C., Scarano M., Ameri P., Ghigliotti G., Guglielmi G., Lotti R., Merlo A.C., Muiesan M.L., Abondio A., Berasi C., Mattiuzzo E., Mutti C., Salvetti M., Pignatelli P., Menichelli D., Pastori D., Tamiya E., Matsumoto T., Takabe T., Yamashita H., Higashiue S., Furuya O., Hiramatsu N., Kasuga K., Kojima S., Komooka M., Kuroyanagi S., Matsuura M., Takemoto T., Yamamoto S., Saito K., Abe T., Ishida I., Iwanami Y., Kataoka S., Moriyama T., Murohashi A., Sasaki A., Nakamura Y., Ueno T., Shimane A., Hamana T., Ichibori H., Inoue T., Itoh M., Iwane S., Kawai H., Kokawa T., Masumoto A., Miyata T., Nakano S., Oishi S., Onishi T., Sawada T., Saito T., Shoda M., Takahashi N., Takaya T., Taniguchi Y., Tsukamoto S., Tsukishiro Y., Tsukiyama Y., Tsunamoto H., Uzu K., Yamamoto H., Yamamoto T., Yokoi K., Yoshida C., Watanabe N., Betsuyaku T., Adachi K., Awane K., Goto D., Sakakibara M., Watanabe M., Ueno H., Hiroe Y., Matsuo K., Ayata K., Fukuda K., Hata Y., Hashimoto K., Matsumi H., Nikaido A., Okamoto S., Sime I., Stirna V., Reinholde I., Hansone S., Kozlovska A., Romanova J., Klincare D., Pontaga N., Dirmans I., Kalnins A., Upite D., Gersamija A., Teleznikovs A., Rozkova N., Safro J., Anguera Camós I., Domenico Dallaglio P., Salguero Bodes R., Arnbas F., Borrego L., Marco A., Jimenez J.R., Gómez-Doblas J.J., Pérez Cabeza A., Ferreira Gonzålez I., Limeres Freire J., Lopez Grau M., Viñolas Prat X., Moreno Weidmann Z., Guerra Ramos J.M., Alonso Martin M.C., Campos Garcia B., Mogro Carranza J.M., Mendez Zurita F.J., Rodriguez Font E., Gonzales Matos C.E., García Hernando V., Lindholm C.-J., Thulin J., Wallén H., Hagwall K., Eliasson K., Lundvall M., Olsson J., Kjellman B., Lind M., Johansson L., Svedberg N., Berglund S., Söderberg J., Zedigh C., Mooe T., Axelsson M., Binsell E., Huber D., Müller C., Danier I., Kühne M., Okamura B., Schoepfer H., Simmen C., Reichlin T., Chollet L., Lam A., Wittmer S., Rickli H., Gall C., Hametner G., Intorp S., Luescher D., Haegeli L., Berg J.C., Ebrahimi R., Auricchio A., Crljenica C., Moccetti T., Monti C., Pasotti E., Petrova I., Rossi M., Mach F., Namdar M., de Groot J., Proost V., Neefs J., Linz D., van Stipdonk T., den Uijl D., Alings M., Schaap J., Segers D., Wouters N., Bartels L., Tieleman R., Pisters R., de Vries T., Selig J., Kuijper A., Bot P., Keijzers M., Verdel G., Tukkie R., van den Bos E., Kauer F., Oemrawsingh R., Stevenhagen J., van Es J., Lip G., Gupta D., Kotalczyk A., Gunstone A., Brixey R.D., Gorog D., Dinarvand D., Gue Y., Kanji R., Memtsas V., Senior R., Bioh G., Wong Y.-K., Child N.. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. LANCET. 2022; 399(10333)DOI:10.1016/S0140-6736(22)00456-1. PMID:35385695. IF:168.900(Q1/1D).

Rao S.V., Kirsch B., Bhatt D.L., Coppolecchia R., Eikelboom J., James S.K., Jones W.S., Keller L., Hermanides R.S., Campo G., Ferreiro J.L., Mundl H., Alexander J.H., Hengstenberg C., Steinwender C., Alber H., Steringer-Mascherbauer R., Schober A., Auer J., Roithinger F.X., Von Lewinski D., Moertl D., Huber K., Coussement P., Hoffer E., Beauloye C., Janssens L., Vranckx P., De Raedt H., Vanassche T., Vrolix M., Rokyta R., Parenica J., Pelouch R., Motovska Z., Alan D., Kettner J., Polasek R., Cermak O., Sedlon P., Hanis J., Novak M., Belohlavek J., Horacek T., Leggewie S., Wenzel P., Vom Dahl J., Sievers B., Pulz J., Schellong S., Clemmensen P., Muller-Hennessen M., Rassaf T., Falukozi J., Ruzsa Z., Tomcsanyi J., Csanadi Z., Herczeg B., Koszegi Z., Vorobcsuk A., Kiss R., Baranyai C., Dezsi C., Merkely B., Lupkovics G., Rossini R., Scherillo M., Sergio Saba P., Calo L., Nassiacos D., Quadri G., Sciahbasi A., Silvio Marenzi G.C., Reimers B., Perna G.P., Sacca S., Fattore L., Brunelli C., Picchi A., Kuramochi T., Kondo K., Aoyama T., Kudoh T., Yamamoto T., Takaya T., Mukai Y., Fukui K., Morioka N., Ando K., Yamamuro A., Morita Y., Koga Y., Watanabe T., Sakamoto T., Shibasaki T., Maebuchi D., Takahashi A., Yonetsu T., Kakuta T., Nishina H., Oemrawsingh R., Dorman R., Oude Ophius T., Prins P., Al Windy N.Y.Y., Zoet-Nugteren S.K., Hermanides R., Van Eck M., Scherptong R., Cornel J.H., Damman P., Bech G., Torquay R., Kietselaer B., Grzelakowski P., Krzysztof D., Budaj A., Miekus P., Przybylski A., Zarebinski M., Balsam P., Szachniewicz J., Gierlotka M., Tycinska A., Iniguez Romo A., Fernandez Ortiz A., Carrasquer Cucarella A., Sanmartin Fernandez M., Sionis A., Bueno Zamora H., Ferreiro Gutierrez J.L., Almenar L., Ferreira Gonzalez I., Pascual Figal D.A., Almendro Delia M., Jimenez Fernandez M., Skeppholm M., Zedigh C., Angeras O., Lauermann J., Erlinge D., Gustafsson R., Mooe T., Utreras A., James S., Grimfjard P., Pedrazzini G., Mach F., Fournier S., Haegeli L., Beer J.H., Leibundgut G., Kobza R., Kaiser C., Kunadian V., Al-Lamee R., Gorog D., Khan S., Trevelyan J., Toor I., Smith J., Purushottam B., Treasure C., Arena F., Vedere A., Henderson D., Gilani S., Jones A., Carrillo-Jimenez R., Gillespie E., Marhefka G., Wang D., Olson C., Bloom S., Iftikhar F., Brabham D., McGinty J., Thompson C., Talano J., Ginete W., Williams M., Masud A., Ariani M., Bitar F., Wang T., Samuelson B.. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. CIRCULATION. 2022; 146(16)DOI:10.1161/CIRCULATIONAHA.122.061612. PMID:36030390. IF:37.800(Q1/1D).

Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).

Radike M., Ben-Aicha S., Gutiérrez M., Hidalgo A., Badimón L., Vilahur G.. Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.06.007. PMID:35809893. IF:5.900(Q1/3D).

Lee G.A., Aktaa S., Baker E., Gale C.P., Yaseen I.F., Gulati G., Asteggiano R., Szmit S., Cohen-Solal A., Abdin A., Jurczak W., Garrido Lopez P., Sverdlov A.L., Tocchetti C.G., Barac A., Parrini I., Zamorano P., Iakobishvili Z., Pudil R., Badimon L., Kirby A.M., Blaes A.H., Farmakis D., Curigliano G., Stephens R., Lyon A.R., Lopez-Fernandez T.. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal-Quality of Care and Clinical Outcomes. 2022; 9(1)DOI:10.1093/ehjqcco/qcac070. PMID:36316010. IF:5.200(Q2/3D).

Pérez de Isla L., Alonso R., Argüeso R., Muñiz-Grijalvo O., Álvarez-Baños P., Badimón L., Watts G.F., Mata P.. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of Clinical Lipidology. 2022; 16(5)DOI:10.1016/j.jacl.2022.07.007. PMID:35906178. IF:4.400(Q2/3D).

Maestro Benedicto A., Asmarats Serra L., Li C.H.P., Mirabet Pérez S.. Percutaneous tricuspid valve repair after orthotopic heart transplantation. Rec: Cardioclinics. 2022; 57(2)DOI:10.1016/j.rccl.2021.12.002. PMID:. IF:(Q/D).

Vilella-Figuerola A., Gallinat A., Escate R., Mirabet S., Padró T., Badimon L.. Systems Biology in Chronic Heart Failure—Identification of Potential miRNA Regulators. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(23)DOI:10.3390/ijms232315226. PMID:36499552. IF:5.600(Q1/3D).

Jimenez-Altayo, F, Marzi, J, Galan, M, Dantas, AP, Ortega, M, Rojas, S, Egea, G, Schenke-Layland, K, Jimenez-Xarrie, E, Planas, AM. Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2022; 42(1)DOI:10.1177/0271678X211033362. PMID:34474613. IF:6.300(Q1/2D).

Valls-Lacalle, L, Puertas-Umbert, L, Varona, S, Martinez-Gonzalez, J, Rodriguez, C, Rodriguez-Sinovas, A. Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion. Antioxidants. 2022; 11(1)DOI:10.3390/antiox11010075. PMID:35052579. IF:7.000(Q1/1D).

Miarons M., Riera P., García-Gil S., Gutiérrez-Nicolás F.. Eficacia y seguridad de dosis altas de irinotecán en pacientes con cáncer colorrectal metastásico tratados con el esquema FOLFIRI en función del genotipo de UGT1A1: Revisión sistemática. Farmacia Hospitalaria. 2022; 46(4)DOI:10.7399/fh.11736. PMID:36183220. IF:(Q/D).

Rivas-Urbina A., Rotllan N., Santos D., Julve J., Sanchez-Quesada J.L., Escolà-Gil J.C.. Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_35. PMID:. IF:(Q/D).

Rivas-Urbina A., Rotllan N., Santos D., Julve J., Escolà-Gil J.C., Sanchez-Quesada J.L.. Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_17. PMID:. IF:(Q/D).

Martos-Folgado I., del Monte-Monge A., Lorenzo C., Busse C.E., Delgado P., Mur S.M., Cobos-Figueroa L., Escolà-Gil J.C., Martín-Ventura J.L., Wardemann H., Ramiro A.R.. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Reports. 2022; 41(2)DOI:10.1016/j.celrep.2022.111468. PMID:36223741. IF:8.800(Q1/2D).

Gourdy, P, Bonadonna, RC, Freemantle, N, Mauricio, D, Muller-Wieland, D, Bigot, G, Mauquoi, C, Ciocca, A, Bonnemaire, M. Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis. Diabetes Therapy. 2022; 13(1)DOI:10.1007/s13300-021-01179-8. PMID:34784005. IF:3.800(Q2/5D).

Jayaraman, S, Perez, A, Minambres, I, Sanchez-Quesada, JL, Gursky, O. Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2022; 1867(1)DOI:10.1016/j.bbalip.2021.159064. PMID:34610468. IF:4.800(Q1/2D).

Chico, A, Corcoy, R. Intensive Insulin Therapy (Basal-Bolus). AMERICAN JOURNAL OF THERAPEUTICS. 2022; 29(1)DOI:10.1097/MJT.0000000000001152. PMID:33031154. IF:4.200(Q2/4D).

Puig-Jove, C, Castelblanco, E, Falguera, M, Hernandez, M, Soldevila, B, Julian, MT, Teis, A, Julve, J, Barranco-Altirriba, M, Franch-Nadal, J, Puig-Domingo, M, Ortega, E, Amigo, N, Alonso, N, Mauricio, D. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(1)DOI:10.1016/j.recesp.2021.02.013. PMID:33785266. IF:5.900(Q1/3D).

Teis A., Castelblanco E., Cediel G., Amigó N., Julve J., Ribalta J., Guardiola M., Franch J., Bermúdez-López M., Codina P., Lupón J., Mauricio D., Alonso N., Bayés-Genís A.. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2021.09.007. PMID:. IF:(Q/D).

Ramon, J, Llaurado, G, Guerri, R, Climent, E, Ballesta, S, Benaiges, D, Lopez-Montesinos, I, Navarro, H, Fernandez, N, Carrera, MJ, Mauricio, D, Flores-Le Roux, JA, Chillaron, JJ. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality. DIABETES CARE. 2022; 45(1)DOI:10.2337/dc21-1321. PMID:34782352. IF:16.200(Q1/1D).

Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).

Genua I., Franch-Nadal J., Navas E., Mata-Cases M., Giménez-Pérez G., Vlacho B., Mauricio D., Goday A.. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5.200(Q1/3D).

Pérez-Montes de Oca A., Julián M.T., Pera G., Caballería L., Morillas R., Torán P., Expósito C., Franch-Nadal J., Mauricio D., Alonso N.. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5.200(Q1/3D).

Moreno-Fernandez J., Chico A., Martínez-Brocca M.A., Beato-Víbora P.I., Vidal M., Piedra M., Quirós C., Muñoz-Rodríguez J.R.. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Diabetes Technology & Therapeutics. 2022; 24(12)DOI:10.1089/dia.2022.0207. PMID:35947087. IF:5.400(Q1/3D).

Casas J.A.V., Sambo M., López C.L., Durán-Poveda M., García J.R.-V., Santos R.J., Llanos M., Navarro-González E., Aller J., Pubul V., Guadalix S., Crespo G., González C., Zafón C., Navarro M., Santamaría-Sandi J., Segura Á., Gajate P., Gómez-Balaguer M., Valdivia J., Puig-Domingo M., Galofré J.C., Castelo B., Villanueva M.J., Argüelles I., Orcajo-Rincón L.. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. European Thyroid Journal. 2022; 11(5)DOI:10.1530/ETJ-21-0111. PMID:35900793. IF:4.700(Q2/3D).

Pérez Pérez A., Ortega Martínez de Victoria E., Arrieta Blanco F., Caixàs Pedragós A., Santos Mazo E., Fernández-Catalina P., Martínez-Hervas S., López-Medina J.A., Suárez-Gutiérrez L., Urgeles Planelles J.R., Gatell Menchén S., Tinahones Madueño F.. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7)DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1.900(Q4/9D).

Tomic D., Morton J.I., Chen L., Salim A., Gregg E.W., Pavkov M.E., Arffman M., Balicer R., Baviera M., Boersma-van Dam E., Brinks R., Carstensen B., Chan J.C.N., Cheng Y.J., Fosse-Edorh S., Fuentes S., Gardiner H., Gulseth H.L., Gurevicius R., Ha K.H., Hoyer A., Jermendy G., Kautzky-Willer A., Keskimäki I., Kim D.J., Kiss Z., Klimek P., Leventer-Roberts M., Lin C.-Y., Lopez-Doriga Ruiz P., Luk A.O.Y., Ma S., Mata-Cases M., Mauricio D., McGurnaghan S., Imamura T., Paul S.K., Peeters A., Pildava S., Porath A., Robitaille C., Roncaglioni M.C., Sugiyama T., Wang K.-L., Wild S.H., Yekutiel N., Shaw J.E., Magliano D.J.. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11)DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44.500(Q1/1D).

van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).

Rivero-Sanchez, L, Gavric, A, Herrero, J, Remedios, D, Alvarez, V, Albeniz, E, Gordillo, J, Puig, I, Lopez-Vicente, J, Huerta, A, Lopez-Ceron, M, Salces, I, Penas, B, Parejo, S, Rodriguez, E, Herraiz, M, Carretero, C, Gimeno-Garcia, AZ, Saperas, E, Alvarez, C, Arnau-Collell, C, Ortiz, O, Sanchez, A, Jung, G, Balaguer, F, Pellise, M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. ENDOSCOPY. 2022; 54(01)DOI:10.1055/a-1328-5405. PMID:33271604. IF:9.300(Q1/1D).

Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).

Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).

Semmler G., Lens S., Meyer E.L., Baiges A., Alvardo-Tapias E., Llop E., Tellez L., Schwabl P., Mauro E., Escudé L., Díez C., Ibañez-Samaniego L., Puente Á., Fortea J.I., Abadía M., Zanetto A., Conthe A., Hernandez-Évole H., Luzko Scheid I.S., Jia J., Yoshiji H., Francque S.M., Tsochatzis E.A., Russo F.P., Crespo G., Forns X., Bañares R., Villanueva C., Hernández-Gea V., Reiberger T., Bosch J., García Pagán J.C., Mandorfer M.. Non-invasive tests for clinically significant portal hypertension after HCV cure. JOURNAL OF HEPATOLOGY. 2022; 77(6)DOI:10.1016/j.jhep.2022.08.025. PMID:36063968. IF:25.700(Q1/1D).

Iborra M., Moret I., Busó E., García-Giménez J.L., Ricart E., Gisbert J.P., Cabré E., Esteve M., Márquez-Mosquera L., García-Planella E., Guardiola J., Pallardó F.V., Serena C., Algaba-Chueca F., Domenech E., Nos P., Beltrán B.. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24)DOI:10.3390/ijms232415881. PMID:36555526. IF:5.600(Q1/3D).